Logo do repositório
 
Publicação

Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel

2024-01Artigo científico Acesso aberto
Ver registo simples
dc.contributor.authorFernandes, M. G. O.
dc.contributor.authorVilariça, A. S.
dc.contributor.authorFernandes, B.
dc.contributor.authorCamacho, C.
dc.contributor.authorSaraiva, C.
dc.contributor.authorEstevinho, F.
dc.contributor.authorBastos, H. Novais e
dc.contributor.authorLopes, J. M.
dc.contributor.authorFidalgo, P.
dc.contributor.authorGarrido, P.
dc.contributor.authorAlves, S.
dc.contributor.authorSilva, S.
dc.contributor.authorSequeira, T.
dc.contributor.authorBarata, F.
dc.date.accessioned2024-12-11T10:22:12Z
dc.date.available2024-12-11T10:22:12Z
dc.date.issued2024-01
dc.description.abstractThe management of NSCLC remains challenging, and the integration of data from predictive biomarkers in routine clinical practice can contribute to an optimal, individualized patient approach, particularly given the rapid emergence of effective targeted therapies. When considering molecular biomarker testing, the choice of the biomarker panel, target population, testing approach, and turnaround time are key issues that, when properly addressed, can improve the survival outcomes of NSCLC patients.eng
dc.description.sponsorshipBoehringer Ingelheim Portuga by Prime Focus
dc.identifier.doi10.1016/j.pulmoe.2022.11.009
dc.identifier.issn2531-0437
dc.identifier.urihttp://hdl.handle.net/10400.1/26447
dc.language.isoeng
dc.peerreviewedyes
dc.publisherInforma UK Limited
dc.relation.hasversionhttps://www.sciencedirect.com/science/article/pii/S2531043723000028?via%3Dihub
dc.relation.ispartofPulmonology
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectOf American Pathologists
dc.subjectTesting Guideline
dc.subjectAcquire resistance
dc.subjectClinical Oncology
dc.subjectEGFR mutation
dc.subjectAssociation
dc.subjectCollege
dc.subjectSelection
dc.subjectNSCLC
dc.subjectALK
dc.titleImproving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage7
oaire.citation.issue1
oaire.citation.startPage4
oaire.citation.titlePulmonology
oaire.citation.volume30
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel.pdf
Tamanho:
281.56 KB
Formato:
Adobe Portable Document Format
Ver/Abrir
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
3.46 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Ver/Abrir

Coleções

ULS_10.1-MED-Artigos